Patients treated with Ditropan XL experienced between 15 to 18 fewer urge incontinence episodes per week. In clinical trials, Ditropan XL was demonstrated to be well-tolerated by patients. The incidence of dry mouth was dose-related. In all controlled trials, seven percent of patients treated with Ditropan XL discontinued because of adverse events. At present, overactive bladder is widely underdiagnosed and undertreated.
Overactive bladder can have a profound impact on patients and disrupt daily routines and activities.
Some patients may become socially isolated or even housebound because they fear the embarrassment of having urinary accidents in public . This material is provided as general medical information only and may not include all side effects or details relevant to a particular individual's treatment. Boards, Forums and Chat Questions by People with MS Answers by caring Neurologists. My Private Calendar Helps Japan Chapter Schapiro, MD Mental Health . Shabas, MD Desert Advent.